An MD graduate from the Karolinska Institutet, Martin Schalling holds a PhD in Molecular Biology. He was an EMBO and a Fulbright Scholar while at MIT and is affiliated with UCSD. He has a three decades-long track record of success in science, with more than 20 publications in journals with high impact factor (over 10), 260 papers/manuscripts and 120 abstracts to meetings and conferences, and a number of research grants from Swedish Research Council, Karolinska Hospital and Institutet, various foundations and industry (support for exploratory research). Professor of Medical Genetics, Mr. Schalling is currently heading the Neurogenetics group at Karolinska Institutet and serves on the steering group of the Center for Molecular Medicine, Swedish Twin Registry as well as other organizations. His professional engagements include: Advisory Board at Max Planch Institute, Group leadership at Center for Molecular Medicine (KI), co-chair of a world congress and Editorial Boards of several journals. He is the coordinator for Karolinska Institutet and Mayo Clinic collaborative platform. Professor Schalling has been involved in entrepreneurial efforts in the biotech as well as the nutraceutical industry for the past decade.